Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism
- Autores
- Obis, Elia; Irazusta, Verónica Patricia; Sanchis, Daniel; Ros, Joaquim; Tamarit, Jordi
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Friedreich ataxia (FRDA) is a hereditary disease caused by deficient frataxin expression. This mitochondrial protein has been related to iron homeostasis, energy metabolism, and oxidative stress. Patients with FRDA experience neurologic alterations and cardiomyopathy, which is the leading cause of death. The specific effects of Frataxin depletion on cardiomyocytes are poorly understood because no appropriate cardiac cellular model is available to researchers. To address this research need, we present a model based on primary cultures of neonatal rat ventricular myocytes (NRVM) and shRNA interference. Using this approach, frataxin was reduced down to 5% to 30% of control protein levels after 7 days of transduction. At this stage the activity and amount of the iron-sulfur protein aconitase, in vitro activities of several OXPHOS components, levels of iron-regulated mRNAs or the ATP/ADP ratio were comparable to controls. However, NRVM exhibited markers of oxidative stress and a disorganized mitochondrial network with enlarged mitochondria. Lipids, the main energy source of heart cells, also underwent a clear metabolic change, indicated by the increased presence of lipid droplets and induction of medium-chain acyl-CoA dehydrogenase. These results indicate that mitochondria and lipid metabolism are primary targets of frataxin deficiency in NRVM. Therefore, they contribute to the understanding of cardiac-specific mechanisms occurring in FRDA and give clues for the design of cardiac specific treatment strategies for FRDA.
Fil: Obis, Elia. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España
Fil: Irazusta, Verónica Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Salta. Instituto de Investigación para la Industria Química (i); Argentina
Fil: Sanchis, Daniel. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España
Fil: Ros, Joaquim. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España
Fil: Tamarit, Jordi. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España - Materia
-
Friedreich Ataxia,
Mitochondria
Iron
Lipid Metabolism - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/4751
Ver los metadatos del registro completo
id |
CONICETDig_d9ad5ae437b3693109835f10d4be7e18 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/4751 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolismObis, EliaIrazusta, Verónica PatriciaSanchis, DanielRos, JoaquimTamarit, JordiFriedreich Ataxia,MitochondriaIronLipid Metabolismhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Friedreich ataxia (FRDA) is a hereditary disease caused by deficient frataxin expression. This mitochondrial protein has been related to iron homeostasis, energy metabolism, and oxidative stress. Patients with FRDA experience neurologic alterations and cardiomyopathy, which is the leading cause of death. The specific effects of Frataxin depletion on cardiomyocytes are poorly understood because no appropriate cardiac cellular model is available to researchers. To address this research need, we present a model based on primary cultures of neonatal rat ventricular myocytes (NRVM) and shRNA interference. Using this approach, frataxin was reduced down to 5% to 30% of control protein levels after 7 days of transduction. At this stage the activity and amount of the iron-sulfur protein aconitase, in vitro activities of several OXPHOS components, levels of iron-regulated mRNAs or the ATP/ADP ratio were comparable to controls. However, NRVM exhibited markers of oxidative stress and a disorganized mitochondrial network with enlarged mitochondria. Lipids, the main energy source of heart cells, also underwent a clear metabolic change, indicated by the increased presence of lipid droplets and induction of medium-chain acyl-CoA dehydrogenase. These results indicate that mitochondria and lipid metabolism are primary targets of frataxin deficiency in NRVM. Therefore, they contribute to the understanding of cardiac-specific mechanisms occurring in FRDA and give clues for the design of cardiac specific treatment strategies for FRDA.Fil: Obis, Elia. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; EspañaFil: Irazusta, Verónica Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Salta. Instituto de Investigación para la Industria Química (i); ArgentinaFil: Sanchis, Daniel. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; EspañaFil: Ros, Joaquim. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; EspañaFil: Tamarit, Jordi. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; EspañaElsevier2014-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/4751Obis, Elia; Irazusta, Verónica Patricia; Sanchis, Daniel; Ros, Joaquim; Tamarit, Jordi; Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism; Elsevier; Free Radical Biology and Medicine; 73; 8-2014; 21-330891-5849enginfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0891584914001853info:eu-repo/semantics/altIdentifier/doi/10.1016/j.freeradbiomed.2014.04.016info:eu-repo/semantics/altIdentifier/issn/0891-5849info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:23:20Zoai:ri.conicet.gov.ar:11336/4751instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:23:20.625CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
title |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
spellingShingle |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism Obis, Elia Friedreich Ataxia, Mitochondria Iron Lipid Metabolism |
title_short |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
title_full |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
title_fullStr |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
title_full_unstemmed |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
title_sort |
Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism |
dc.creator.none.fl_str_mv |
Obis, Elia Irazusta, Verónica Patricia Sanchis, Daniel Ros, Joaquim Tamarit, Jordi |
author |
Obis, Elia |
author_facet |
Obis, Elia Irazusta, Verónica Patricia Sanchis, Daniel Ros, Joaquim Tamarit, Jordi |
author_role |
author |
author2 |
Irazusta, Verónica Patricia Sanchis, Daniel Ros, Joaquim Tamarit, Jordi |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Friedreich Ataxia, Mitochondria Iron Lipid Metabolism |
topic |
Friedreich Ataxia, Mitochondria Iron Lipid Metabolism |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Friedreich ataxia (FRDA) is a hereditary disease caused by deficient frataxin expression. This mitochondrial protein has been related to iron homeostasis, energy metabolism, and oxidative stress. Patients with FRDA experience neurologic alterations and cardiomyopathy, which is the leading cause of death. The specific effects of Frataxin depletion on cardiomyocytes are poorly understood because no appropriate cardiac cellular model is available to researchers. To address this research need, we present a model based on primary cultures of neonatal rat ventricular myocytes (NRVM) and shRNA interference. Using this approach, frataxin was reduced down to 5% to 30% of control protein levels after 7 days of transduction. At this stage the activity and amount of the iron-sulfur protein aconitase, in vitro activities of several OXPHOS components, levels of iron-regulated mRNAs or the ATP/ADP ratio were comparable to controls. However, NRVM exhibited markers of oxidative stress and a disorganized mitochondrial network with enlarged mitochondria. Lipids, the main energy source of heart cells, also underwent a clear metabolic change, indicated by the increased presence of lipid droplets and induction of medium-chain acyl-CoA dehydrogenase. These results indicate that mitochondria and lipid metabolism are primary targets of frataxin deficiency in NRVM. Therefore, they contribute to the understanding of cardiac-specific mechanisms occurring in FRDA and give clues for the design of cardiac specific treatment strategies for FRDA. Fil: Obis, Elia. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España Fil: Irazusta, Verónica Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Salta. Instituto de Investigación para la Industria Química (i); Argentina Fil: Sanchis, Daniel. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España Fil: Ros, Joaquim. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España Fil: Tamarit, Jordi. Universitat de Leida. Departament de Ciències Mèdiques Bàsiques; España |
description |
Friedreich ataxia (FRDA) is a hereditary disease caused by deficient frataxin expression. This mitochondrial protein has been related to iron homeostasis, energy metabolism, and oxidative stress. Patients with FRDA experience neurologic alterations and cardiomyopathy, which is the leading cause of death. The specific effects of Frataxin depletion on cardiomyocytes are poorly understood because no appropriate cardiac cellular model is available to researchers. To address this research need, we present a model based on primary cultures of neonatal rat ventricular myocytes (NRVM) and shRNA interference. Using this approach, frataxin was reduced down to 5% to 30% of control protein levels after 7 days of transduction. At this stage the activity and amount of the iron-sulfur protein aconitase, in vitro activities of several OXPHOS components, levels of iron-regulated mRNAs or the ATP/ADP ratio were comparable to controls. However, NRVM exhibited markers of oxidative stress and a disorganized mitochondrial network with enlarged mitochondria. Lipids, the main energy source of heart cells, also underwent a clear metabolic change, indicated by the increased presence of lipid droplets and induction of medium-chain acyl-CoA dehydrogenase. These results indicate that mitochondria and lipid metabolism are primary targets of frataxin deficiency in NRVM. Therefore, they contribute to the understanding of cardiac-specific mechanisms occurring in FRDA and give clues for the design of cardiac specific treatment strategies for FRDA. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/4751 Obis, Elia; Irazusta, Verónica Patricia; Sanchis, Daniel; Ros, Joaquim; Tamarit, Jordi; Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism; Elsevier; Free Radical Biology and Medicine; 73; 8-2014; 21-33 0891-5849 |
url |
http://hdl.handle.net/11336/4751 |
identifier_str_mv |
Obis, Elia; Irazusta, Verónica Patricia; Sanchis, Daniel; Ros, Joaquim; Tamarit, Jordi; Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism; Elsevier; Free Radical Biology and Medicine; 73; 8-2014; 21-33 0891-5849 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0891584914001853 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.freeradbiomed.2014.04.016 info:eu-repo/semantics/altIdentifier/issn/0891-5849 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842981287904673792 |
score |
12.493442 |